US Broker Ratings

Insmed Incorporated (INSM): Analyst Consensus Signals Strong Growth Potential Amid Biotech Innovations

Insmed Incorporated (NASDAQ: INSM), a pioneering player in the biotechnology sector, has captured investor attention with its innovative treatments targeting serious and rare diseases. Based in Bridgewater, New Jersey, Insmed..

Doximity, Inc. (DOCS): Investor Outlook on a $12.66 Billion Healthcare Innovator with a Strong Upside

Doximity, Inc. (DOCS), a leading player in the Health Information Services industry, has become a pivotal digital platform for healthcare professionals in the United States. With a market capitalization of..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 25.85% Upside Potential in Medical Devices

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector specializing in medical devices, stands out as a compelling investment opportunity for individual investors. With a market capitalization of..

Elevance Health, Inc. (ELV) Stock Analysis: A Strong Buy with 8% Upside Potential

Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans industry, stands as a formidable player in the U.S. healthcare sector with a significant market capitalization of $78.54 billion...

Investor Outlook: Dr. Reddy’s Laboratories Ltd (RDY) Offers Stable Growth and Strategic Opportunities

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) is a prominent player in the global pharmaceutical landscape, headquartered in Hyderabad, India. Operating across North America, Europe, India, Russia, and other international markets,..

Align Technology, Inc. (ALGN) Stock Analysis: Understanding the 34.86% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a leader in the medical instruments and supplies industry, has long been at the forefront of dental innovation with its Invisalign clear aligners and iTero..

Amgen Inc. (AMGN) Stock Analysis: Evaluating a Healthcare Giant with a 4.3% Upside

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, continues to be a compelling choice for investors seeking exposure to the drug manufacturing industry. With a market capitalization of..

DaVita Inc. (DVA) Stock Analysis: Evaluating the 19.56% Potential Upside

For investors eyeing the healthcare sector, DaVita Inc. (NYSE: DVA) presents an intriguing opportunity, particularly given its potential upside of 19.56% based on current analyst evaluations. As a leading provider..

Cencora, Inc. (COR) Stock Analysis: A Strong Performer with a Robust 116.71% ROE

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, stands as a formidable player in the healthcare sector, specifically in medical distribution. With a rich history dating back to 1871,..

Haleon plc (HLN) Stock Analysis: Evaluating a 22.78% Upside Potential Amid Global Consumer Healthcare Demand

Haleon plc (HLN) stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With its headquarters in Weybridge, United Kingdom, and a..

Gilead Sciences, Inc. (GILD) Stock Analysis: Navigating Potential Upside with Robust Dividends

Gilead Sciences, Inc. (NASDAQ: GILD), a biopharmaceutical giant known for its innovative treatments in areas of unmet medical need, stands as a compelling consideration for investors in the healthcare sector...

Hologic, Inc. (HOLX) Stock Analysis: Exploring the 4.40% Potential Upside

As the healthcare sector continues to evolve, Hologic, Inc. (NASDAQ: HOLX) stands out as a key player in the medical instruments and supplies industry. With a market capitalization of $15.54..

BioNTech SE (BNTX) Stock Analysis: Exploring a 28.63% Upside Amidst Strong Buy Ratings

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has been a focal point for investors seeking to navigate the complexities of the healthcare industry. Headquartered in Mainz,..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 16.74% Potential Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a stalwart in the healthcare sector, is making waves in the medical devices industry with its innovative cardiovascular treatments. Headquartered in Irvine, California, the company..

United Therapeutics Corporation (UTHR) Stock Analysis: Evaluating a 13.73% Potential Upside for Investors

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, offers a compelling investment opportunity with its focus on addressing unmet medical needs in chronic and life-threatening diseases...

Natera, Inc. (NTRA) Stock Analysis: A Diagnostic Powerhouse with Promising Upside

Natera, Inc. (NASDAQ: NTRA), a leader in the diagnostics and research industry, continues to make waves in the healthcare sector with its innovative molecular testing services. Based in Austin, Texas,..

McKesson Corporation (MCK) Stock Analysis: Unveiling Growth Potential with a 6.45% Upside

McKesson Corporation (NYSE: MCK) continues to capture the attention of investors as a prominent player in the healthcare sector. With a sprawling market cap of $97.77 billion, this medical distribution..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating Growth Amidst a Potential -5.64% Downside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a formidable player in the biotechnology sector, continues to attract investor attention with its pioneering work in RNA interference therapeutics. With a robust market capitalization..

The Cooper Companies, Inc. (COO) Stock Analysis: Eyeing a 15% Upside in Healthcare Innovation

The Cooper Companies, Inc. (NYSE: COO), a key player in the healthcare sector specializing in medical instruments and supplies, is capturing the attention of investors with its robust market presence..

Agilent Technologies, Inc. (A) Stock Analysis: Understanding the 4.68% Upside Potential

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector with a focus on diagnostics and research, is capturing investor attention with its promising growth metrics and a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds